Differential effects of diazepam and MPEP on habituation and neuro-behavioural processes in inbred mice

Behavioral and Brain Functions

Volumn 8, Issue , 2012, Pages

  Salomons, Amber R ^a,b   Pinzon, Nathaly E ^a   Boleij, Hetty ^a,b   Kirchhoff, Susanne ^a,b   Arndt, Saskia S ^a,b   Nordquist, Rebecca E ^b,c   Lindemann, Lothar ^d   Jaeschke, Georg ^d   Spooren, Will ^d   Ohl, Frauke ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Anxiety; Behavior; Benzodiazepines; C Fos; Cortisosterone; mGluR5 antagonist

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; ANXIOLYTIC AGENT; CORTICOSTERONE; DIAZEPAM; METABOTROPIC RECEPTOR 5;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN FUNCTION; COGNITION; DRUG ACTIVITY; EMOTIONALITY; GENE EXPRESSION; HABITUATION; IMMUNOHISTOCHEMISTRY; LIMBIC CORTEX; LOCOMOTION; MALE; MOUSE; NONHUMAN; ONCOGENE C FOS; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT;

ANIMALS; AVOIDANCE LEARNING; DIAZEPAM; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED BALB C; MICE, INBRED STRAINS; PYRIDINES; RANDOM ALLOCATION;

EID: 84861988555     PISSN: None     EISSN: 17449081     Source Type: Journal    
DOI: 10.1186/1744-9081-8-30     Document Type: Article

References (66)

1. Ohl F, Arndt SS, van der Staay FJ. Pathological anxiety in animals. Vet J 2008, 175:18-26. 10.1016/j.tvjl.2006.12.013, 17321766.
2. Salomons AR, van Luijk JA, Reinders NR, Kirchhoff S, Arndt SS, Ohl F. Identifying emotional adaptation: behavioural habituation to novelty and immediate early gene expression in two inbred mouse strains. Genes Brain Behav 2010, 9:1-10. 10.1111/j.1601-183X.2009.00527.x, 19751395.
3. McNaughton N. Cognitive dysfunction resulting from hippocampal hyperactivity-a possible cause of anxiety disorder?. Pharmacol Biochem Behav 1997, 56:603-611. 10.1016/S0091-3057(96)00419-4, 9130284.
4. Belzung C, Berton F. Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of trait anxiety. Behav Pharmacol 1997, 8:541-548. 10.1097/00008877-199711000-00012, 9832968.
5. Belzung C, Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 2001, 125:141-149. 10.1016/S0166-4328(01)00291-1, 11682105.
6. Salomons AR, Kortleve T, Reinders NR, Kirchhoff S, Arndt SS, Ohl F. Susceptibility of a potential animal model for pathological anxiety to chronic mild stress. Behav Brain Res 2010, 209:241-248. 10.1016/j.bbr.2010.01.050, 20138918.
7. Rodgers RJ, Boullier E, Chatzimichalaki P, Cooper GD, Shorten A. Contrasting phenotypes of C57BL/6JOlaHsd, 129 S2/SvHsd and 129/SvEv mice in two exploration-based tests of anxiety-related behaviour. Physiol Behav 2002, 77:301-310. 10.1016/S0031-9384(02)00856-9, 12419406.
8. Tang X, Sanford LD. Home cage activity and activity-based measures of anxiety in 129P3/J, 129X1/SvJ and C57BL/6 J mice. Physiol Behav 2005, 84:105-115. 10.1016/j.physbeh.2004.10.017, 15642613.
9. Belzung C, LePape G. Comparison of different behaviorbehavioural test situations used in psychopharmacology for measurement of anxiety. Physiol Behav 2002, 566:23-628.
10. Ohl F. Animal models of anxiety. Handb Exp Pharmacol 2005, 35-69.
11. Dere E, de Souza Silva MA, Topic B, Fiorillo C, Li JS, Sadile A. Aged endothelial nitric oxide synthase knockout mice exhibit higher mortality concomitant with impaired open-field habituation and alterations in forebrain neurotransmitter levels. Genes Brain Behav 2002, 1:204-213. 10.1034/j.1601-183X.2002.10402.x, 12882365.
12. Leussis MP, Bolivar VJ. Habituation in rodents: A review of behavior, neurobiology, and genetics. Neurosci Biobehav Rev 2006, 30:1045-1064. 10.1016/j.neubiorev.2006.03.006, 16774787.
13. Faravelli C, Rosi S, Truglia E. Treatments. Benzodiazepines 2003, 315-338. Blackwell Science, Oxford, Nutt DJ, Ballenger JC.
14. Shader RI, Greenblatt DJ. Use of benzodiazepines in anxiety disorders. N Engl J Med 1993, 328:1398-1405. 10.1056/NEJM199305133281907, 8292115.
15. Fernandes C, Arnot MI, Irvine EE, Bateson AN, Martin IL, File SE. The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam. Psychopharmacology 1999, 145:251-259. 10.1007/s002130051056, 10494573.
16. Gasparini F, Lingenhohl K, Stoehr N, Flor PJ, Heinrich M, Vranesic I. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 1993, 38:1493-1503.
17. Nordquist RE, Durkin S, Jaeschke G, Spooren W. Stress-induced hyperthermia: effects of acute and repeated dosing of MPEP. Eur J Pharmacol 2007, 568:199-202. 10.1016/j.ejphar.2007.04.034, 17537432.
18. Spooren WP, Vassout A, Neijt HC, Kuhn R, Gasparini F, Roux S. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Ther 2000, 295:1267-1275.
19. Spooren WP, Gasparini F, Salt TE, Kuhn R. Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders. Trends Pharmacol Sci 2001, 22:331-337. 10.1016/S0165-6147(00)01694-1, 11431019.
20. Piechaczyk M, Blanchard JM. c-fos proto-oncogene regulation and function. Crit Rev Oncology/Hematology 1994, 17:93-131.
21. Chan RKW, Brown ER, Ericsson A, Kovacs KJ, Sawchenko PE. Comparison of Two Immediate-Early Genes, c-fos and NGFI-B, as Markers for Functional Activation in Stress-related Neuroendocrine Circuitry. J of Neuroscience 1993, 13:5126-5138.
22. Ohl F, Sillaber I, Binder E, Keck ME, Holsboer F. Differential analysis of behavior and diazepam-induced alterations in C57BL/6 N and BALB/c mice using the modified hole board test. J Psychiatr Res 2001, 35:147-154. 10.1016/S0022-3956(01)00017-6, 11461710.
23. Arzt E, Holsboer F. CRF signaling: molecular specificity for drug targeting in the CNS. Trends Pharmacol Sci 2006, 27:531-538. 10.1016/j.tips.2006.08.007, 16935354.
24. Muigg P, Hoelzl U, Palfrader K, Neumann I, Wigger A, Landgraf R. Altered Brain Activation Pattern Associated With Drug-Induced Attenuation of Enhanced Depression-Like Behavior in Rats Bred for High Anxiety. Biol Psychiatry 2007, 61:782-796. 10.1016/j.biopsych.2006.08.035, 17224133.
25. Nguyen NK, Keck ME, Hetzenauer A, Thoeringer CK, Wurst W, Deussing JM. Conditional CRF receptor 1 knockout mice show altered neuronal activation pattern to mild anxiogenic challenge. Psychopharmacology (Berl) 2006, 188:374-385.
26. Franklin KGB, Paxinos G. The mouse brain in stereotaxic coordinates. Academic 1997, Press.
27. Field A. Discovering statistics using SPSS 2009, SAGE Publications Ltd, London, 3.
28. Conover WJ, Iman RL. Analysis of covariance using the rank transformation. Biometrics 1982, 38:715-724. 10.2307/2530051, 7171697.
29. Algina J, Kesselman HJ. Detecting repeated measures effects with univariate and multivariate statistics. Psychological Methods 1997, 2:208-218.
30. Rodgers RJ, Davies B, Shore R. Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline. Genes Brain Behav 2002, 1:242-251. 10.1034/j.1601-183X.2002.10406.x, 12882369.
31. Griebel G, Belzung C, Misslin R, Vogel E. The free-exploratory paradigm: an effective method for measuring neophobic behaviour in mice and testing potential neophobia-reducing drugs. Behav Pharmacol 1993, 4:637-644.
32. Griebel G, Belzung C, Perrault G, Sanger DJ. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology (Berl) 2000, 148:164-170.
33. Robertson HA. Benzodiazepine receptors in "emotional" and "non-emotional" mice; comparison of four strains. Eur J Pharmacol 1979, 56:163-166. 10.1016/0014-2999(79)90447-3, 572777.
34. Mikkelsen JD, Soderman A, Kiss A, Mirza N. Effects of benzodiazepines receptor agonists on the hypothalamic-pituitary-adrenocortical axis. Eur J Pharmacol 2005, 519:223-230. 10.1016/j.ejphar.2005.06.049, 16125698.
35. Makowska IJ, Weary DM. Rat aversion to induction with inhalant anaesthetics. Applied Animal Behaviour Science 2009, 119:229-235.
36. Bogeart MJ, Groenink L, Oosting RS, Westphal KG, van der Gugten J, Olivier B. Mouse strain differences in autonomic responses. Genes Brain Behav 2006, 5:139-149. 10.1111/j.1601-183X.2005.00143.x, 16507005.
37. Ballard TM, Woolley ML, Prinssen E, Huwyler J, Porter R, Spooren W. The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison. Psychopharmacology (Berl) 2005, 179:218-229.
38. Rodgers RJ, Coa BJ, Dalvi A, Holmes A. Animal models of anxiety: an ethological perspective. Braz J Med Biol Res 1997, 30:289-304. 10.1590/S0100-879X1997000300002, 9246227.
39. Ohl F, Holsboer F, Landgraf R. The modified hole board as differential screen for behaviour in rodents. Behav Res Methods Instrum Comput 2001, 33:392-397. 10.3758/BF03195393, 11591071.
40. Blanchard DC, Griebel G, Blanchard RJ. Mouse defense behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosc. Biobeh Rev 2001, 25:205-218.
41. Goldman-Rakic PS. Architecture of the prefrontal cortex and the central executive. Ann N Y Acad Sci 1995, 769:71-83. 10.1111/j.1749-6632.1995.tb38132.x, 8595045.
42. Herman JP, Ostrander MM, Mueller NK, Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1201-1213. 10.1016/j.pnpbp.2005.08.006, 16271821.
43. Makino S, Hashimoto K, Gold PW. Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress. Pharmacol Biochem Behav 2002, 73:147-158. 10.1016/S0091-3057(02)00791-8, 12076734.
44. Sheehan TP, Chambers RA, Russell DS. Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Res Brain Res Rev 2004, 46:71-117.
45. McNaughton N, Corr PJ. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci Biobehav Rev 2004, 28:285-305. 10.1016/j.neubiorev.2004.03.005, 15225972.
46. Singewald N, Salchner P, Sharp T. Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 2003, 53:275-283. 10.1016/S0006-3223(02)01574-3, 12586446.
47. George SA, Hutson PH, Stephens DN. Differential effects of MPEP and diazepam in tests of conditioned emotional response and Pavlovian-to-instrumental transfer suggests 'anxiolytic' effects are mediated by different mechanisms. Psychopharmacology (Berl) 2009, 204:499-509.
48. Romano C, Sesma MA, McDonald CT, O'Malley K, van den Pol AN, Olney JW. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 1995, 355:455-469. 10.1002/cne.903550310, 7636025.
49. Shigemoto R, Nomura S, Ohishi H, Sugihara H, Nakanishi S, Mizuno N. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett 1993, 163:53-57. 10.1016/0304-3940(93)90227-C, 8295733.
50. Benquet P, Gee CE, Gerber U. Two distinct signaling pathways upregulate NMDA receptor responses via two distinct metabotropic glutamate receptor subtypes. J Neurosci 2002, 22:9679-9686.
51. Gerber U, Gee CE, Benquet P. Metabotropic glutamate receptors: intracellular signaling pathways. Curr Opin Pharmacol 2007, 7:56-61. 10.1016/j.coph.2006.08.008, 17055336.
52. Pintor A, Pezzola A, Reggio R, Quarta D, Popoli P. The mGlu5 receptor agonist CHPG stimulates striatal glutamate release: possible involvement of A2A receptors. Neuroreport 2000, 11:3611-3614. 10.1097/00001756-200011090-00042, 11095529.
53. Kemp JA, McKernan RM. NMDA receptor pathways as drug targets. Nat Neurosci 2002, 5:1039-1042. Suppl, 10.1038/nn936, 12403981.
54. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci U S A 1993, 90:6591-6595. 10.1073/pnas.90.14.6591, 46978, 8393571.
55. Simon AB, Gorman JM. Advances in the treatment of anxiety: targeting glutamate. NeuroRx 2003, 3:57-68.
56. Thomas LS, Jane DE, Gasparini F, Croucher MJ. Glutamate release inhibiting properties of the novel mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP): complementary in vitro and in vivo evidence. Neuropharmacology 2001, 41:523-527. 10.1016/S0028-3908(01)00091-0, 11543773.
57. Camp M, Norcross M, Whittle N, Feyder M, D'Hanis W, Yilmazer-Hanke D. Impaired Pavlovian fear extinction is a common phenotype across genetic lineages of the 129 inbred mouse strain. Genes Brain Behav 2009, 8:744-752. 10.1111/j.1601-183X.2009.00519.x, 2783364, 19674120.
58. Quirk GJ, Garcia R, Gonzalez-Lima F. Prefrontal mechanisms in extinction of conditioned fear. Biol Psychiatry 2006, 60:337-343. 10.1016/j.biopsych.2006.03.010, 16712801.
59. Davidson RJ. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry 2002, 51:68-80. 10.1016/S0006-3223(01)01328-2, 11801232.
60. Beuzen A, Belzung C. Link between emotional memory and anxiety states: a study by principal component analysis. Physiol Behav 1995, 58:111-118. 10.1016/0031-9384(95)00013-9, 7667407.
61. Kuribara H, Asahi T. Assessment of the anxiolytic and amnesic effects of three benzodiazepines, diazepam, alprazolam and triazolam, by conflict and non-matching to sample tests in mice. Nihon Shinkei Seishin Yakurigaku Zasshi 1997, 17:1-6.
62. Tomaz C, Dickinson-Anson H, McGaugh JL. Basolateral amygdala lesions block diazepam-induced anterograde amnesia in an inhibitory avoidance task. PNAS USA 1992, 89:3615-3619. 10.1073/pnas.89.8.3615, 48919, 1565657.
63. Barker GR, Bashir ZI, Brown MW, Warburton EC. A temporally distinct role for group I and group II metabotropic glutamate receptors in object recognition memory. Learn Mem 2006, 13:178-186. 10.1101/lm.77806, 1409835, 16585793.
64. Christoffersen GR, Simonyi A, Schachtman TR, Clausen B, Clement D, Bjerre VK. MGlu5 antagonism impairs exploration and memory of spatial and non-spatial stimuli in rats. Behav Brain Res 2008, 191:235-245. 10.1016/j.bbr.2008.03.032, 18471908.
65. Bouwknecht JA, Paylor R. Behavioral and physiological mouse assays for anxiety: a survey in nine mouse strains. Behav Brain Res 2002, 136:489-501. 10.1016/S0166-4328(02)00200-0, 12429412.
66. Cryan JF, Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nature Reviews 2005, 4:775-789. 10.1038/nrd1825, 16138108.